1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Pap Smear Test 1.2.3 HPV DNA Test 1.3 Market by Application 1.3.1 Global Human Papillomavirus (HPV) Testing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Diagnostic Centers 1.3.3 Hospitals 1.3.4 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Papillomavirus (HPV) Testing Market Perspective (2017-2028) 2.2 Human Papillomavirus (HPV) Testing Growth Trends by Region 2.2.1 Human Papillomavirus (HPV) Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Human Papillomavirus (HPV) Testing Historic Market Size by Region (2017-2022) 2.2.3 Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028) 2.3 Human Papillomavirus (HPV) Testing Market Dynamics 2.3.1 Human Papillomavirus (HPV) Testing Industry Trends 2.3.2 Human Papillomavirus (HPV) Testing Market Drivers 2.3.3 Human Papillomavirus (HPV) Testing Market Challenges 2.3.4 Human Papillomavirus (HPV) Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue 3.1.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue (2017-2022) 3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Players (2017-2022) 3.2 Global Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue 3.4 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio 3.4.1 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Testing Revenue in 2021 3.5 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served 3.6 Key Players Human Papillomavirus (HPV) Testing Product Solution and Service 3.7 Date of Enter into Human Papillomavirus (HPV) Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Papillomavirus (HPV) Testing Breakdown Data by Type 4.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Type (2017-2022) 4.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028) 5 Human Papillomavirus (HPV) Testing Breakdown Data by Application 5.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Application (2017-2022) 5.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Human Papillomavirus (HPV) Testing Market Size (2017-2028) 6.2 North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) 6.3 North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Human Papillomavirus (HPV) Testing Market Size (2017-2028) 7.2 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) 7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (2017-2028) 8.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) 8.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Human Papillomavirus (HPV) Testing Market Size (2017-2028) 9.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) 9.3 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size (2017-2028) 10.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) 10.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Detail 11.1.2 Roche Business Overview 11.1.3 Roche Human Papillomavirus (HPV) Testing Introduction 11.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.1.5 Roche Recent Development 11.2 Agilent Technologies 11.2.1 Agilent Technologies Company Detail 11.2.2 Agilent Technologies Business Overview 11.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Introduction 11.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.2.5 Agilent Technologies Recent Development 11.3 Becton, DickinsonandCompany 11.3.1 Becton, DickinsonandCompany Company Detail 11.3.2 Becton, DickinsonandCompany Business Overview 11.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Introduction 11.3.4 Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.3.5 Becton, DickinsonandCompany Recent Development 11.4 QiagenN.V. 11.4.1 QiagenN.V. Company Detail 11.4.2 QiagenN.V. Business Overview 11.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Introduction 11.4.4 QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.4.5 QiagenN.V. Recent Development 11.5 Thermo FisherScientificInc. 11.5.1 Thermo FisherScientificInc. Company Detail 11.5.2 Thermo FisherScientificInc. Business Overview 11.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Introduction 11.5.4 Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.5.5 Thermo FisherScientificInc. Recent Development 11.6 Abbott Laboratories 11.6.1 Abbott Laboratories Company Detail 11.6.2 Abbott Laboratories Business Overview 11.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Introduction 11.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.6.5 Abbott Laboratories Recent Development 11.7 HologicInc. 11.7.1 HologicInc. Company Detail 11.7.2 HologicInc. Business Overview 11.7.3 HologicInc. Human Papillomavirus (HPV) Testing Introduction 11.7.4 HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.7.5 HologicInc. Recent Development 11.8 CepheidInc. 11.8.1 CepheidInc. Company Detail 11.8.2 CepheidInc. Business Overview 11.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Introduction 11.8.4 CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.8.5 CepheidInc. Recent Development 11.9 SeegeneInc. 11.9.1 SeegeneInc. Company Detail 11.9.2 SeegeneInc. Business Overview 11.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Introduction 11.9.4 SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.9.5 SeegeneInc. Recent Development 11.10 TakaraBio Inc. 11.10.1 TakaraBio Inc. Company Detail 11.10.2 TakaraBio Inc. Business Overview 11.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Introduction 11.10.4 TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.10.5 TakaraBio Inc. Recent Development 11.11 DaAnGeneof SunYat-SenUniversity 11.11.1 DaAnGeneof SunYat-SenUniversity Company Detail 11.11.2 DaAnGeneof SunYat-SenUniversity Business Overview 11.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Introduction 11.11.4 DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.11.5 DaAnGeneof SunYat-SenUniversity Recent Development 11.12 PromegaCorporation 11.12.1 PromegaCorporation Company Detail 11.12.2 PromegaCorporation Business Overview 11.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Introduction 11.12.4 PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.12.5 PromegaCorporation Recent Development 11.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) 11.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail 11.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview 11.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Introduction 11.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development 11.14 Enzo Biochem Inc. 11.14.1 Enzo Biochem Inc. Company Detail 11.14.2 Enzo Biochem Inc. Business Overview 11.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Introduction 11.14.4 Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.14.5 Enzo Biochem Inc. Recent Development 11.15 NorgenBiotek 11.15.1 NorgenBiotek Company Detail 11.15.2 NorgenBiotek Business Overview 11.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Introduction 11.15.4 NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.15.5 NorgenBiotek Recent Development 11.16 DiagCorBioscienceIncLtd 11.16.1 DiagCorBioscienceIncLtd Company Detail 11.16.2 DiagCorBioscienceIncLtd Business Overview 11.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Introduction 11.16.4 DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.16.5 DiagCorBioscienceIncLtd Recent Development 11.17 Hybribio Limited 11.17.1 Hybribio Limited Company Detail 11.17.2 Hybribio Limited Business Overview 11.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Introduction 11.17.4 Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.17.5 Hybribio Limited Recent Development 11.18 ZytovisionGmbH 11.18.1 ZytovisionGmbH Company Detail 11.18.2 ZytovisionGmbH Business Overview 11.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Introduction 11.18.4 ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.18.5 ZytovisionGmbH Recent Development 11.19 ArborVitaCorporation 11.19.1 ArborVitaCorporation Company Detail 11.19.2 ArborVitaCorporation Business Overview 11.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Introduction 11.19.4 ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.19.5 ArborVitaCorporation Recent Development 11.20 Medical& BiologicalLaboratoriesCo., Ltd 11.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Detail 11.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview 11.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Introduction 11.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Development 11.21 Fujirebio Diagnostics 11.21.1 Fujirebio Diagnostics Company Detail 11.21.2 Fujirebio Diagnostics Business Overview 11.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Introduction 11.21.4 Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) 11.21.5 Fujirebio Diagnostics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Pap Smear Test Table 3. Key Players of HPV DNA Test Table 4. Global Human Papillomavirus (HPV) Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Human Papillomavirus (HPV) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Human Papillomavirus (HPV) Testing Market Share by Region (2017-2022) Table 8. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Human Papillomavirus (HPV) Testing Market Share by Region (2023-2028) Table 10. Human Papillomavirus (HPV) Testing Market Trends Table 11. Human Papillomavirus (HPV) Testing Market Drivers Table 12. Human Papillomavirus (HPV) Testing Market Challenges Table 13. Human Papillomavirus (HPV) Testing Market Restraints Table 14. Global Human Papillomavirus (HPV) Testing Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Human Papillomavirus (HPV) Testing Market Share by Players (2017-2022) Table 16. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021) Table 17. Ranking of Global Top Human Papillomavirus (HPV) Testing Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Human Papillomavirus (HPV) Testing Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Human Papillomavirus (HPV) Testing Product Solution and Service Table 21. Date of Enter into Human Papillomavirus (HPV) Testing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2017-2022) Table 25. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2023-2028) Table 27. Global Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2017-2022) Table 29. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2023-2028) Table 31. North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million) Table 41. Roche Company Detail Table 42. Roche Business Overview Table 43. Roche Human Papillomavirus (HPV) Testing Product Table 44. Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 45. Roche Recent Development Table 46. Agilent Technologies Company Detail Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies Human Papillomavirus (HPV) Testing Product Table 49. Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 50. Agilent Technologies Recent Development Table 51. Becton, DickinsonandCompany Company Detail Table 52. Becton, DickinsonandCompany Business Overview Table 53. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product Table 54. Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 55. Becton, DickinsonandCompany Recent Development Table 56. QiagenN.V. Company Detail Table 57. QiagenN.V. Business Overview Table 58. QiagenN.V. Human Papillomavirus (HPV) Testing Product Table 59. QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 60. QiagenN.V. Recent Development Table 61. Thermo FisherScientificInc. Company Detail Table 62. Thermo FisherScientificInc. Business Overview Table 63. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product Table 64. Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 65. Thermo FisherScientificInc. Recent Development Table 66. Abbott Laboratories Company Detail Table 67. Abbott Laboratories Business Overview Table 68. Abbott Laboratories Human Papillomavirus (HPV) Testing Product Table 69. Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 70. Abbott Laboratories Recent Development Table 71. HologicInc. Company Detail Table 72. HologicInc. Business Overview Table 73. HologicInc. Human Papillomavirus (HPV) Testing Product Table 74. HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 75. HologicInc. Recent Development Table 76. CepheidInc. Company Detail Table 77. CepheidInc. Business Overview Table 78. CepheidInc. Human Papillomavirus (HPV) Testing Product Table 79. CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 80. CepheidInc. Recent Development Table 81. SeegeneInc. Company Detail Table 82. SeegeneInc. Business Overview Table 83. SeegeneInc. Human Papillomavirus (HPV) Testing Product Table 84. SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 85. SeegeneInc. Recent Development Table 86. TakaraBio Inc. Company Detail Table 87. TakaraBio Inc. Business Overview Table 88. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product Table 89. TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 90. TakaraBio Inc. Recent Development Table 91. DaAnGeneof SunYat-SenUniversity Company Detail Table 92. DaAnGeneof SunYat-SenUniversity Business Overview Table 93. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) TestingProduct Table 94. DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 95. DaAnGeneof SunYat-SenUniversity Recent Development Table 96. PromegaCorporation Company Detail Table 97. PromegaCorporation Business Overview Table 98. PromegaCorporation Human Papillomavirus (HPV) TestingProduct Table 99. PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 100. PromegaCorporation Recent Development Table 101. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail Table 102. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview Table 103. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) TestingProduct Table 104. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 105. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development Table 106. Enzo Biochem Inc. Company Detail Table 107. Enzo Biochem Inc. Business Overview Table 108. Enzo Biochem Inc. Human Papillomavirus (HPV) TestingProduct Table 109. Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 110. Enzo Biochem Inc. Recent Development Table 111. NorgenBiotek Company Detail Table 112. NorgenBiotek Business Overview Table 113. NorgenBiotek Human Papillomavirus (HPV) TestingProduct Table 114. NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 115. NorgenBiotek Recent Development Table 116. DiagCorBioscienceIncLtd Company Detail Table 117. DiagCorBioscienceIncLtd Business Overview Table 118. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) TestingProduct Table 119. DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 120. DiagCorBioscienceIncLtd Recent Development Table 121. Hybribio Limited Company Detail Table 122. Hybribio Limited Business Overview Table 123. Hybribio Limited Human Papillomavirus (HPV) TestingProduct Table 124. Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 125. Hybribio Limited Recent Development Table 126. ZytovisionGmbH Company Detail Table 127. ZytovisionGmbH Business Overview Table 128. ZytovisionGmbH Human Papillomavirus (HPV) TestingProduct Table 129. ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 130. ZytovisionGmbH Recent Development Table 131. ArborVitaCorporation Company Detail Table 132. ArborVitaCorporation Business Overview Table 133. ArborVitaCorporation Human Papillomavirus (HPV) TestingProduct Table 134. ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 135. ArborVitaCorporation Recent Development Table 136. Medical& BiologicalLaboratoriesCo., Ltd Company Detail Table 137. Medical& BiologicalLaboratoriesCo., Ltd Business Overview Table 138. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) TestingProduct Table 139. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 140. Medical& BiologicalLaboratoriesCo., Ltd Recent Development Table 141. Fujirebio Diagnostics Company Detail Table 142. Fujirebio Diagnostics Business Overview Table 143. Fujirebio Diagnostics Human Papillomavirus (HPV) TestingProduct Table 144. Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million) Table 145. Fujirebio Diagnostics Recent Development Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Papillomavirus (HPV) Testing Market Share by Type: 2021 VS 2028 Figure 2. Pap Smear Test Features Figure 3. HPV DNA Test Features Figure 4. Global Human Papillomavirus (HPV) Testing Market Share by Application in 2021 & 2028 Figure 5. Diagnostic Centers Case Studies Figure 6. Hospitals Case Studies Figure 7. Clinic Case Studies Figure 8. Human Papillomavirus (HPV) Testing Report Years Considered Figure 9. Global Human Papillomavirus (HPV) Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Human Papillomavirus (HPV) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Human Papillomavirus (HPV) Testing Market Share by Region: 2021 VS 2028 Figure 12. Global Human Papillomavirus (HPV) Testing Market Share by Players in 2021 Figure 13. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Testing Revenue in 2021 Figure 15. North America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028) Figure 17. United States Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028) Figure 21. Germany Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Human Papillomavirus (HPV) Testing Market Share by Region (2017-2028) Figure 29. China Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028) Figure 37. Mexico Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028) Figure 41. Turkey Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Roche Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 44. Agilent Technologies Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 45. Becton, DickinsonandCompany Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 46. QiagenN.V. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 47. Thermo FisherScientificInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 48. Abbott Laboratories Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 49. HologicInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 50. CepheidInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 51. SeegeneInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 52. TakaraBio Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 53. DaAnGeneof SunYat-SenUniversity Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 54. PromegaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 55. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 56. Enzo Biochem Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 57. NorgenBiotek Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 58. DiagCorBioscienceIncLtd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 59. Hybribio Limited Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 60. ZytovisionGmbH Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 61. ArborVitaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 62. Medical& BiologicalLaboratoriesCo., Ltd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 63. Fujirebio Diagnostics Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Roche Agilent Technologies Becton, DickinsonandCompany QiagenN.V. Thermo FisherScientificInc. Abbott Laboratories HologicInc. CepheidInc. SeegeneInc. TakaraBio Inc. DaAnGeneof SunYat-SenUniversity PromegaCorporation GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Enzo Biochem Inc. NorgenBiotek DiagCorBioscienceIncLtd Hybribio Limited ZytovisionGmbH ArborVitaCorporation Medical& BiologicalLaboratoriesCo., Ltd Fujirebio Diagnostics